Thyroid cancer review 3: Management of medullary and undifferentiated thyroid cancer

International Journal of Clinical Practice

Volumn 60, Issue 1, 2006, Pages 80-84

  Nix, P A ^a   Nicolaides, A ^a   Coatesworth, Andrew Peter ^a  

^a YORK HOSPITAL   (United Kingdom)

Author keywords

Medullary and anaplastic thyroid cancer; Thyroid lymphoma

Indexed keywords

ANTINEOPLASTIC AGENT; CALCITONIN; IODINE 131; THYROGLOBULIN; THYROTROPIN; THYROXINE;

ANAPLASTIC CARCINOMA; ASPIRATION BIOPSY; CALCITONIN BLOOD LEVEL; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; DISEASE ASSOCIATION; FOLLOW UP; HUMAN; LYMPHOMA; MOLECULAR GENETICS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SQUAMOUS CELL CARCINOMA; SUBTOTAL THYROIDECTOMY; SURVIVAL RATE; SURVIVAL TIME; THYROID CANCER; THYROID MEDULLARY CARCINOMA; THYROID PARAFOLLICULAR CELL; TREATMENT PLANNING; TUMOR DIFFERENTIATION; CARCINOMA; GENETICS; METHODOLOGY; THYROID TUMOR;

CARCINOMA; CARCINOMA, SQUAMOUS CELL; HUMANS; LYMPHOMA; NEOPLASM STAGING; THYROID NEOPLASMS;

EID: 33644839887     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2005.00673.x     Document Type: Review

References (37)

1. Segev DL, Umbricht C, Zeiger MA. Molecular pathogenesis of thyroid cancer. Surg Oncol 2003; 12: 69-90.
2. Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-95 [see comments]. Cancer 1998; 83: 2638-48.
3. Wilson JA. Effective Head and Neck Cancer Management 3rd edn. London: British Association of Otorhinolaryngologists Head and Neck Surgeons.
4. British Thyroid Association. Guidelines for the Management of Thyroid Cancer in Adults 2002. Available at http://www.british-thyroid-association.org/guidelines.htm
5. American Association of Clinical Endocrinologists/American Association of Endocrine Surgeons. Medical/surgical guidelines for clinical practice: Management of thyroid carcinoma. American Association of Clinical Endocrinologists. American College of Endocrinology. Endocr Pract 2001; 7: 202-20.
6. Mazzaferri EL, Kloos RT. Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 2001 2005; 86: 1447-63.
7. Thyroid Carcinoma. National Comprehensive Cancer Network Guidelines 2005. Available at http://www.nccn.org/professionals/physician
8. Caruso DR, O'Dorisio TM, Mazzaferri EL. Multiple endocrine neoplasia. Curr Opin Oncol 1991; 3:103-8.
9. Caruso DR, O'Dorisio TM, Mazzaferri EL. Multiple endocrine neoplasia. Curr Opin Oncol 1990; 2: 108-16.
10. Takami H. Medullary thyroid carcinoma and multiple endocrine neoplasia type 2. Endocr Pathol 2003; 14: 123-31.
11. Wells SA Jr, Dilley WG, Farndon JA et al. Early diagnosis and treatment of medullary thyroid carcinoma. Arch Intern Med 1985; 145: 1248-52.
12. Cohen R, Campos JM, Salaun C et al. Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d'Etudes des Tumeurs a Calcitonine (GETC). J Clin Endocrinol Metab 2000; 85: 919-22.
13. Ruegemer JJ, Hay ID, Bergstralh EJ et al. Distant metastases in differentiated thyroid carcinoma: A multivariate analysis of prognostic variables. J Clin Endocrinol Metab 1988; 67: 501-8.
14. Gorman B, Charboneau JW, James EM et al. Medullary thyroid carcinoma: role of high-resolution US. Radiology 1987; 162 (1 Part 1): 147-50.
15. Greene FL, Sobin LH. The TNM system: Our language for cancer care. J Surg Oncol 2002; 80: 119-20.
16. Fleming JB, Lee JE, Bouvet M et al. Surgical strategy for the treatment of medullary thyroid carcinoma. Ann Surg 1999; 230: 697-707.
17. Gonzalez-Yebra B, Medrano ME, Mantilla A et al. Penetrance of inherited medullary thyroid carcinoma and genotype-phenotype correlation in a large multiple endocrine neoplasia type 2A family with C634Y RET mutation. Endocr Pathol 2003; 14: 71-80.
18. Wells SA Jr, Chi DD, Toshima K et al. Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A. Ann Surg 1994; 220: 237-47.
19. Klein I, Esik O, Homolya V et al. Molecular genetic diagnostic program of multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma syndromes in Hungary. J Endocrinol 2001; 170: 661-6.
20. Ledger GA, Khosla S, Lindor NM et al. Genetic testing in the diagnosis and management of multiple endocrine neoplasia type II. Ann Intern Med 1995; 122: 118-24.
21. Eng C. Seminars in medicine of the Beth Israel Hospital, Boston. The RET proto-oncogene in multiple endocrine neoplasia type 2 and Hirschsprung's disease. N Engl J Med 1996; 335: 943 -51.
22. Gagel RF, Cote GJ, Martins Bugalho MJ et al. Clinical use of molecular information in the management of multiple endocrine neoplasia type 2A. J Intern Med 1995; 238: 333-41.
23. Samaan NA, Schultz PN, Hickey RC et al. The results of various modalities of treatment of well differentiated thyroid carcinomas: A retrospective review of 1599 patients. J Clin Endocrinol Metab 1992; 75: 714-20.
24. Samaan NA, Schultz PN, Haynie TP, Ordonez NG. Pulmonary metastasis of differentiated thyroid carcinoma: Treatment results in 101 patients. J Clin Endocrinol Metab 1985; 60: 376-80.
25. Cap J, Ryska A, Rehorkova P et al. Sensitivity and specificity of the fine needle aspiration biopsy of the thyroid: Clinical point of view. Clin Endocrinol (Oxf) 1999; 51: 509-15.
26. Mazzaferri EL. An overview of the management of papillary and follicular thyroid carcinoma. Thyroid 1999; 9: 421-7.
27. Tan RK, Finley RK III, Driscoll D et al. Anaplastic carcinoma of the thyroid: A 24-year experience. Head Neck 1995; 17: 41-7.
28. Ain KB. Anaplastic thyroid carcinoma: A therapeutic challenge. Semin Surg Oncol 1999; 16: 64-9.
29. Ain KB. Anaplastic thyroid carcinoma: Behavior, biology, and therapeutic approaches. Thyroid 1998; 8: 715-26.
30. Carcangiu ML, Steeper T, Zampi G, Rosai J. Anaplastic thyroid carcinoma. A study of 70 cases. Am J Clin Pathol 1985; 83: 135-58.
31. Rosai J, Saxen EA, Woolner L. Undifferentiated and poorly differentiated carcinoma. Semin Diagn Pathol 1985; 2: 123-36.
32. Takashima S, Morimoto S, Ikezoe J et al. CT evaluation of anaplastic thyroid carcinoma. AJR Am J Roentgenol 1990; 154: 1079-85.
33. Giuffrida D, Gharib H. Anaplastic thyroid carcinoma: Current diagnosis and treatment. Ann Oncol2000; 11: 1083-9.
34. Junor EJ, Paul J, Reed NS. Anaplastic thyroid carcinoma: 91 patients treated by surgery and radiotherapy. Eur J Surg Oncol 1992; 18: 83-8.
35. Lam KY, Lo CY, Liu MC. Primary squamous cell carcinoma of the thyroid gland: An entity with aggressive clinical behaviour and distinctive cytokeratin expression profiles. Histopathology 2001; 39: 279-86.
36. Segal K, Sidi J, Abraham A et al. Pure squamous cell carcinoma and mixed adenosquamous cell carcinoma of the thyroid gland. Head Neck Surg 1984; 6: 1035-42.
37. Sahoo M, Bal CS, Bhatnagar D. Primary squamous-cell carcinoma of the thyroid gland: New evidence in support of follicular epithelial cell origin. Diagn Cytopathol 2002; 27: 227-31.